Conversion of calcineurin inhibitor treatment to target of rapamycin inhibitor treatment versus continuation of calcineurin inhibitor treatment for liver transplant recipients

This review aims to assess the benefits and harms of conversion of calcineurin inhibitor treatment to mTor inhibitor treatment compared with continuation of calcineurin inhibitor treatment for liver transplant recipients.

This is a protocol.

Share/Save